What Is KPV? Anti-Inflammatory Tripeptide Research

KPV is a short tripeptide that's drawn attention in inflammation research. Despite being only three amino acids long, it's the C-terminal fragment of a much-studied signaling hormone, and that lineage is what makes it interesting as a research model. This overview explains what KPV is, where it comes from, and the anti-inflammatory pathways it's studied in — as a research reference standard only. See the KPV research kit for specifications.

What is KPV?

KPV is a tripeptide composed of three amino acids: lysine (K), proline (P), and valine (V) — hence the name. It corresponds to the C-terminal sequence (residues 11–13) of alpha-melanocyte-stimulating hormone (alpha-MSH), a peptide hormone with well-documented anti-inflammatory activity in the research literature. KPV is studied as the minimal active fragment that retains alpha-MSH's anti-inflammatory signal without the pigmentation-related effects associated with the full hormone.

The appeal of a three-residue molecule is partly practical: it's small, inexpensive to synthesize, and chemically simple, which makes it a clean model for isolating a single signaling effect. In a research setting, fewer moving parts means fewer confounding variables when attributing an observed result to the compound.

Where does KPV come from?

Alpha-MSH is a 13-amino-acid hormone derived from the larger pro-opiomelanocortin (POMC) precursor. Researchers identified that much of its anti-inflammatory activity localizes to the final three residues — the KPV sequence. Mapping activity down to that minimal fragment is a classic structure-function exercise: by testing progressively shorter sequences, the literature converged on KPV as the smallest piece that still carries the anti-inflammatory signal. Isolating that tripeptide gives a small, stable molecule that's convenient to synthesize and study, which is why KPV appears so often in inflammation-pathway research.

What is KPV studied for?

KPV research is almost entirely about inflammatory signaling. The KPV reference standard is used in models examining the mechanisms below.

NF-kB signaling

The most-cited mechanism is modulation of the NF-kB pathway — a master regulator of inflammatory gene expression. NF-kB normally sits inactive in the cytoplasm and translocates to the nucleus to switch on inflammatory genes. In-vitro studies examine how KPV influences that translocation step and the downstream production of pro-inflammatory cytokines, treating the pathway as the central readout for the compound's activity.

Cytokine and immune-cell models

KPV is studied in models of intestinal and epithelial inflammation, where researchers measure pro-inflammatory cytokine output (such as IL-6 and TNF-alpha in cell-based assays) and immune-cell activity. Its small size is itself a point of interest because it influences how the molecule moves in and around cells in these systems — a property researchers specifically examine in epithelial-barrier models.

Comparison with the parent hormone

A common experimental design places KPV side by side with full-length alpha-MSH to test whether the tripeptide reproduces the parent hormone's anti-inflammatory signal. This comparison is what established KPV as a useful minimal model rather than just a degradation fragment, and it remains a standard reference point in the literature. Because KPV lacks the residues responsible for alpha-MSH's melanocyte (pigmentation) signaling, the comparison also isolates the anti-inflammatory arm of the hormone's activity from its other effects — a separation that is hard to achieve with the full molecule.

• NF-kB translocation and activation in cell-based assays
• Pro-inflammatory cytokine expression (e.g., IL-6, TNF-alpha) models
• Intestinal and epithelial-barrier inflammation models
• Head-to-head comparison against the parent alpha-MSH hormone

Why KPV is a useful research model

KPV's value as a research tool comes from its simplicity. With only three amino acids and a single dominant signaling theme, it isolates the anti-inflammatory question more cleanly than larger, multi-function molecules. That makes it a good model for asking "does this pathway respond to alpha-MSH's minimal fragment?" without the confounds a bigger peptide would introduce. Its stability and low synthesis cost reinforce that practicality, which is why a tripeptide punches well above its size in the inflammation literature.

KPV and tissue-repair research

Because inflammation and tissue repair are intertwined — uncontrolled inflammation impairs healing in most models — KPV is sometimes studied in the same recovery context as compounds like BPC-157. The two address different parts of the picture: KPV the inflammatory-signaling side, BPC-157 the angiogenesis and structural-repair side. They aren't substitutes; they sit on different mechanistic axes that recovery research designs sometimes examine together. See our what is BPC-157 overview for that companion model, or the recovery research roundup for how the cluster fits together.

How KPV is supplied

Eon Research supplies KPV lyophilized in multi-vial research kits from our US facility with tracking. The freeze-dried tripeptide is stable for shipping and is held cold and out of light until use. It is reconstituted with bacteriostatic water before use in research; the reconstitution calculator computes the concentration and volumes for any vial size, and the KPV research kit ships within 48 hours.